Abstract
Pierre Fabre SA, in collaboration with Bristol-Myers Squibb Co, is developing vinflunine, a fluorinated vinca alkaloid, as a potential anticancer agent.
MeSH terms
-
Antineoplastic Agents, Phytogenic / adverse effects
-
Antineoplastic Agents, Phytogenic / chemistry
-
Antineoplastic Agents, Phytogenic / metabolism
-
Antineoplastic Agents, Phytogenic / therapeutic use*
-
Apoptosis / drug effects
-
Clinical Trials as Topic
-
Drug Delivery Systems
-
Endothelial Cells / drug effects
-
Humans
-
Infusions, Intravenous
-
Neoplasms / drug therapy*
-
Neovascularization, Physiologic / drug effects*
-
Vinblastine / adverse effects
-
Vinblastine / analogs & derivatives*
-
Vinblastine / chemistry
-
Vinblastine / metabolism
-
Vinblastine / therapeutic use*
Substances
-
Antineoplastic Agents, Phytogenic
-
vinflunine
-
Vinblastine